1985
DOI: 10.1111/j.1526-4610.1985.hed2507376.x
|View full text |Cite
|
Sign up to set email alerts
|

Menstrual Migraine and Other Hormonal Aspects of Migraine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
41
1
3

Year Published

1986
1986
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(49 citation statements)
references
References 7 publications
2
41
1
3
Order By: Relevance
“…A number of findings provide support for a relationship between hormonal variations and migraine. These include evidence indicating that many women with migraine report worsening of their headaches around the time of menstruation [Edelson, 1985;Greene, 1967;Lance and Anthony, 1966]. In fact, menstrual migraine (i.e., 90% of attacks of MO occur in association with menstruation) is experienced by 24-25% of females with MO [Rasmussen, 1993;Russell et al, 1996].…”
Section: Genetic Influence and Sex-limitationmentioning
confidence: 96%
“…A number of findings provide support for a relationship between hormonal variations and migraine. These include evidence indicating that many women with migraine report worsening of their headaches around the time of menstruation [Edelson, 1985;Greene, 1967;Lance and Anthony, 1966]. In fact, menstrual migraine (i.e., 90% of attacks of MO occur in association with menstruation) is experienced by 24-25% of females with MO [Rasmussen, 1993;Russell et al, 1996].…”
Section: Genetic Influence and Sex-limitationmentioning
confidence: 96%
“…Dentre as cefaléias primárias, a influência do ciclo menstrual permanece mais bem determinada e estabelecida para a migrânea [4][5][6] . Estudos clínicos mostram que, em mulheres migranosas, a freqüência de migrânea associada à menstruação chega a 60% -70% 5,7 . A classificação das cefaléias, em particular da migrâ-nea, relacionadas ao ciclo menstrual, permanece conceitualmente problemática.…”
unclassified
“…Ergotamine derivatives may be used for short-term prophylaxis but must be used only during the vulnerable period to avoid ergot dependence [24]. Effective regimens include ergotamine tartrate one tablet twice daily or half suppository every night taken over the vulnerable perimenstrual time period.…”
Section: Short-term Preventionmentioning
confidence: 99%